申请人:Glenmark Life Science Limited
公开号:US20200172560A1
公开(公告)日:2020-06-04
The present invention relates to a process for the preparation of crisaborole, the process comprising reacting a compound of formula IIa with a compound of formula III to give a compound of formula IV and converting the compound of formula IV to crisaborole. The present invention also relates to a process for the preparation of crystalline crisaborole.